You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ApoA-I

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glycation of apoA-I and Diabetic Atherogenesis

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • overnight fasting
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Dec 11, 2022

Advanced Lipoproptein Profiling and Cardiovascular Risk

Recruiting
  • Familial Hypercholesterolemia
  • Atherosclerosis
  • Additionnal blood samples
  • Paris, France
    Hôpital de la Pitié Salpêtrière
Aug 2, 2022

Liver Failure Trial in Antalya

Completed
  • Liver Failure
    • Antalya, Turkey
      AkdenizU
    Jul 13, 2023

    Dyslipidemia, Atherosclerosis, Acute Coronary Syndrome Trial in Dallas (RVX000222, Placebo)

    Completed
    • Dyslipidemia
    • +3 more
    • Dallas, Texas
      Covance Clinical Research Unit, Inc.
    Nov 1, 2022

    Cardiovascular Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Fx-5A peptide complex)

    Recruiting
    • Cardiovascular Disease
    • Fx-5A peptide complex
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 7, 2022

    Hyperlipidemia Trial in Beijing (AK102, Placebo)

    Recruiting
    • Hyperlipidemia
    • AK102
    • Placebo
    • Beijing, China
      Peking University First Hospital
    Feb 15, 2022

    HDL, Health, Subjective Trial in Nashville (Dietary supplementation)

    Active, not recruiting
    • HDL
    • Health, Subjective
    • Dietary supplementation
    • Nashville, Tennessee
      Hypertension Institute
    Apr 4, 2022

    Cholesterol, HDL, Lipid Metabolism, Inborn Errors, Tangier Disease Trial in Philadelphia (3H-cholesterol bound to albumin)

    Suspended
    • Cholesterol, HDL
    • +4 more
    • 3H-cholesterol bound to albumin
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jul 14, 2022

    Hyperlipidemia Trial in Nanchang (AK102, Placebo)

    Recruiting
    • Hyperlipidemia
    • AK102
    • Placebo
    • Nanchang, Jiangxi, China
      The Third Hospital of Nanchang
    Feb 15, 2022

    Acute Myocardial Infarction Trial in Worldwide (CSL112, Placebo)

    Completed
    Has Results
    • Acute Myocardial Infarction
    • CSL112
    • Placebo
    • Birmingham, Alabama
    • +188 more
    Feb 19, 2021

    Hyperlipidemia Trial in Hangzhou, Shanghai (AK102, Placebo)

    Recruiting
    • Hyperlipidemia
    • AK102
    • Placebo
    • Hangzhou, Zhejiang, China
    • +1 more
    Feb 18, 2022

    Elevated Triglycerides Trial in London, Toronto (GFA-918, Placebo)

    Completed
    • Elevated Triglycerides
    • GFA-918
    • Placebo
    • London, Ontario, Canada
    • +1 more
    Dec 21, 2021

    Families-At-risk for Interstitial Lung Disease Study

    Active, not recruiting
    • Interstitial Lung Disease
    • Idiopathic Pulmonary Fibrosis
      • New York, New York
        Columbia University Irving Medical Center
      Jul 19, 2022

      Coronary Artery Disease, Diabetes, Type 2, Dyslipidemias Trial in Shanghai

      Recruiting
      • Coronary Artery Disease
      • +4 more
        • Shanghai, China
          Ruijin Hospital, Shanghai Jiaotong University School of Medicine
        Nov 1, 2021

        Insulin Sensitivity, Obesity, Overweight Trial in Pavia (500 mg of artichoke extract, Placebo)

        Completed
        • Insulin Sensitivity
        • +2 more
        • 500 mg of artichoke extract
        • Placebo
        • Pavia, PV, Italy
          Azienda di Servizi alla Persona ''Istituto Santa Margherita''
        Oct 29, 2020

        Dyslipidemias, High Cholesterol, Hypercholesterolemia Trial in United States (Placebo, Obicetrapib)

        Recruiting
        • Dyslipidemias
        • +4 more
        • Anniston, Alabama
        • +126 more
        Dec 8, 2022

        Familial Chylomicronemia Syndrome Trial in Canada, Sweden, United States (Olezarsen)

        Recruiting
        • Familial Chylomicronemia Syndrome
        • Huntington Beach, California
        • +10 more
        Aug 4, 2022

        Lipids, Lipid Metabolism, Healthy Trial in Reading, Guildford (High SFA diet (Diet 1), Low SFA diet (Diet 2))

        Completed
        • Lipids
        • +2 more
        • High SFA diet (Diet 1)
        • Low SFA diet (Diet 2)
        • Reading, Berkshire, United Kingdom
        • +1 more
        Oct 15, 2021

        Diet Modification, HDL, Inflammation Trial in Davis (Mediterranean Diet, Fast food diet)

        Completed
        • Diet Modification
        • +2 more
        • Mediterranean Diet
        • Fast food diet
        • Davis, California
          UC Davis Ragle Center for Human Nutrition
        Aug 5, 2021

        Dyslipidemias, Overweight and Obesity Trial in Guadalajara (NUTRIGENETIC DIET INTERVENTION, CONVENTIONAL DIET INTERVENTION)

        Completed
        • Dyslipidemias
        • Overweight and Obesity
        • NUTRIGENETIC DIET INTERVENTION
        • CONVENTIONAL DIET INTERVENTION
        • Guadalajara, Jalisco, Mexico
          Institute of Translational Nutrigenetics and Nutrigenomics, Depa
        Jan 13, 2022

        Coronary Artery Disease, Coronary Atherosclerosis, Nicotine Dependence Trial in Warsaw (heated tobacco - lifestyle intervention)

        Not yet recruiting
        • Coronary Artery Disease
        • +2 more
        • heated tobacco - lifestyle intervention
        • Warsaw, Poland
          National Institute of Cardiology
        Dec 27, 2022

        Hypertriglyceridemia, Atherosclerotic Cardiovascular Disease, Severe Hypertriglyceridemia Trial in Canada, United States

        Active, not recruiting
        • Hypertriglyceridemia
        • +2 more
        • Lincoln, California
        • +23 more
        Nov 23, 2022

        Cancer Related Fatigue Trial in Stavanger (REBECCA-assisted intervention)

        Recruiting
        • Cancer Related Fatigue
        • REBECCA-assisted intervention
        • Stavanger, Rogaland, Norway
          Stavanger University Hospital
        Nov 6, 2023

        Inflammation Trial in Boston (Animal Diet, Plant Diet)

        Active, not recruiting
        • Inflammation
        • Animal Diet
        • Plant Diet
        • Boston, Massachusetts
          Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts
        Apr 15, 2021

        Genetic Pathways Leading to Fatty Liver and Atherogenic

        Enrolling by invitation
        • Non-alcoholic Fatty Liver
        • +2 more
        • Lipoprotein kinetics
        • Helsinki, Finland
        • +1 more
        Apr 11, 2022